Little House Capital LLC Sells 750 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Little House Capital LLC trimmed its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 5.6% in the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 12,629 shares of the healthcare conglomerate’s stock after selling 750 shares during the quarter. UnitedHealth Group comprises approximately 1.8% of Little House Capital LLC’s portfolio, making the stock its 17th biggest position. Little House Capital LLC’s holdings in UnitedHealth Group were worth $6,389,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in UNH. Centerpoint Advisory Group purchased a new position in shares of UnitedHealth Group in the 4th quarter worth $458,000. Palumbo Wealth Management LLC boosted its position in UnitedHealth Group by 12.9% in the fourth quarter. Palumbo Wealth Management LLC now owns 5,505 shares of the healthcare conglomerate’s stock worth $2,785,000 after purchasing an additional 628 shares during the last quarter. bLong Financial LLC purchased a new stake in shares of UnitedHealth Group during the 4th quarter valued at about $337,000. TigerOak Management L.L.C. purchased a new position in shares of UnitedHealth Group in the fourth quarter worth approximately $2,361,000. Finally, Puff Wealth Management LLC purchased a new stake in UnitedHealth Group during the fourth quarter valued at approximately $273,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Down 1.4 %

Shares of NYSE:UNH opened at $523.48 on Friday. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The firm has a market capitalization of $481.75 billion, a PE ratio of 33.77, a price-to-earnings-growth ratio of 1.45 and a beta of 0.61. The business has a 50 day simple moving average of $523.11 and a two-hundred day simple moving average of $563.18.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. During the same period last year, the company earned $5.83 earnings per share. The business’s revenue for the quarter was up 6.8% compared to the same quarter last year. On average, equities analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

Analyst Ratings Changes

A number of equities research analysts have recently issued reports on the stock. Truist Financial cut their price objective on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a research report on Monday, January 6th. Wells Fargo & Company decreased their price objective on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 28th. Barclays reduced their target price on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a report on Friday, January 17th. Deutsche Bank Aktiengesellschaft upped their price target on shares of UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research report on Tuesday, December 3rd. Finally, Oppenheimer lifted their target price on shares of UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a research note on Friday, December 6th. One investment analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Buy” and an average target price of $629.32.

Insider Activity

In other news, Director Timothy Patrick Flynn purchased 1,000 shares of the business’s stock in a transaction dated Friday, January 17th. The shares were purchased at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the purchase, the director now owns 4,500 shares in the company, valued at approximately $2,302,065. This represents a 28.57 % increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through this link. Insiders own 0.33% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.